These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28087583)

  • 41. Diagnosing diabetes mellitus: performance of hemoglobin A1c point-of-care instruments in general practice offices.
    Sølvik UØ; Røraas T; Christensen NG; Sandberg S
    Clin Chem; 2013 Dec; 59(12):1790-801. PubMed ID: 23958846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sample stability for the measurement of hemoglobin A1c.
    Mercadanti M; Caleffi A; Targher G; Lippi G
    Diabetes Res Clin Pract; 2010 Oct; 90(1):e13-4. PubMed ID: 20816260
    [No Abstract]   [Full Text] [Related]  

  • 43. Point: The reporting of estimated glucose with hemoglobin A1c.
    Sacks DB; Bergenstal RM; McLaughlin S
    Clin Chem; 2010 Apr; 56(4):545-6. PubMed ID: 20167694
    [No Abstract]   [Full Text] [Related]  

  • 44. Evaluation of a new hemoglobin A1c analyzer for point-of-care testing.
    Zhou R; Wang W; Song ZX; Tong Q; Wang QT
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28220976
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessing adherence to American Diabetes Association recommendations for hemoglobin A1C goals.
    Folsom L; Harris D; Mennito S; Bowlby D; Simpson K
    J S C Med Assoc; 2013 Dec; 109(4):126, 128-9. PubMed ID: 24908912
    [No Abstract]   [Full Text] [Related]  

  • 46. Accuracy and Precision of a Point-of-Care HbA1c Test.
    Arnold WD; Kupfer K; Little RR; Amar M; Horowitz B; Godbole N; Hvidsten Swensen M; Li Y; San George RC
    J Diabetes Sci Technol; 2020 Sep; 14(5):883-889. PubMed ID: 30854894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Biological surveillance of diabetes mellitus: point of view of the diabetologist].
    Grimaldi A
    Ann Biol Clin (Paris); 1999; 57(4):458-62. PubMed ID: 10432369
    [No Abstract]   [Full Text] [Related]  

  • 48. Elevated Donor Hemoglobin A1C Impairs Kidney Graft Survival From Deceased Donors With Diabetes Mellitus: A National Analysis.
    Bendersky VA; Mulvihill MS; Yerokun BA; Ezekian B; Davis RP; Hartwig MG; Barbas AS
    Exp Clin Transplant; 2019 Oct; 17(5):613-618. PubMed ID: 30674242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the Quo-Test hemoglobin A1c point-of-care instrument: second chance.
    Lenters-Westra E; Slingerland RJ
    Clin Chem; 2010 Jul; 56(7):1191-3. PubMed ID: 20431053
    [No Abstract]   [Full Text] [Related]  

  • 50. Hemoglobinopathies and Hemoglobin A1c in Diabetes Mellitus.
    Klonoff DC
    J Diabetes Sci Technol; 2020 Jan; 14(1):3-7. PubMed ID: 30897962
    [No Abstract]   [Full Text] [Related]  

  • 51. [Level of hemoglobin A1c and modified blood serum albumin in patients with diabetes mellitus].
    Korolev VA; Golovskaia GG; Selivanova KF; Moldovan KI; Borisenko SN
    Vopr Med Khim; 1991; 37(3):41-3. PubMed ID: 1949683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [HbAI as an indicator of blood glucose regulation in diabetic patients].
    Oimomi M; Ishikawa K; Kawasaki T; Kubota S; Takagi K; Tanke G; Yoshimura Y; Baba S
    Nihon Naika Gakkai Zasshi; 1983 Sep; 72(9):1159-62. PubMed ID: 6663185
    [No Abstract]   [Full Text] [Related]  

  • 53. Prospective evaluation of accuracy, precision, and reproducibility of an at-home hemoglobin A1c sampling kit.
    Parkes J; Ray R; Kerestan S; Davis H; Ginsberg B
    Diabetes Technol Ther; 1999; 1(4):411-9. PubMed ID: 11474825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variation between Point-of-care and Laboratory HbA1c testing in Clinical Practice.
    Fellows SE; Cipriano GC
    P R Health Sci J; 2019 Sep; 38(3):189-191. PubMed ID: 31536634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analytical performance and clinical use of a hemoglobin A1c point-of-care analyzer in a pediatric unit.
    Dupuy AM; Elong-Bertard C; Badiou S; Barrot A; Bargnoux AS; Cristol JP
    J Diabetes Sci Technol; 2013 Sep; 7(5):1408-9. PubMed ID: 24124971
    [No Abstract]   [Full Text] [Related]  

  • 56. Managing chronic diseases in rural aged care facilities using point-of-care testing systems.
    Khalil H; Halls H; Chambers H; Walker J; Shephard MD
    Rural Remote Health; 2013; 13(3):2597. PubMed ID: 23889519
    [No Abstract]   [Full Text] [Related]  

  • 57. [Limits of chromatographic determination of glycated hemoglobin (Hb A1c) in diabetes mellitus in presence of abnormal hemoglobins].
    Pashintseva LP; Budantseva TA; Troitskaia OV; Orlova EV; Kleshcheva LV
    Klin Lab Diagn; 2001 Jul; (7):39-43. PubMed ID: 11530531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glycosylated haemoglobin. Part I: Measurement and clinical interpretation.
    Ashby JP; Deacon AC; Frier BM
    Diabet Med; 1985 Mar; 2(2):83-5. PubMed ID: 2952406
    [No Abstract]   [Full Text] [Related]  

  • 59. Point-of-care assays for hemoglobin A(1c): is performance adequate?
    Little RR; Lenters-Westra E; Rohlfing CL; Slingerland R
    Clin Chem; 2011 Sep; 57(9):1333-4. PubMed ID: 21712548
    [No Abstract]   [Full Text] [Related]  

  • 60. American Diabetes Association recommendations on haemoglobin A1c use in diabetes diagnosis: time to include point-of-care devices?
    Sreenan S; Tormey W
    Ann Clin Biochem; 2016 Sep; 53(Pt 5):620. PubMed ID: 26792778
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.